Palmitoyl oligopeptide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Palmitoyl oligopeptide
Accession Number
DB11297
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
  • Palmitoyl oligopeptide
  • Palmitoyl tripeptide-1
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Buddate Reges Intensive TreatmentPalmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)CreamTopicalBuddate Co Ltd2017-01-012017-01-02Us
Buddate Reges Intensive TreatmentPalmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)CreamTopicalBuddate Co Ltd2017-01-01Not applicableUs
Cosmeceutical Mask PackPalmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-212013-10-29Us
Cosmeceutical Mask PackPalmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
Dermaheal Cosmeceutical Mask Pack PlusPalmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Buddate Reges Intensive TreatmentPalmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)CreamTopicalBuddate Co Ltd2017-01-012017-01-02Us
Buddate Reges Intensive TreatmentPalmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)CreamTopicalBuddate Co Ltd2017-01-01Not applicableUs
Cosmeceutical Mask PackPalmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-212013-10-29Us
Cosmeceutical Mask PackPalmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
Dermaheal Cosmeceutical Mask Pack PlusPalmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
Categories
Not Available
UNII
RV743D216M
CAS number
147732-56-7
Weight
Average: 578.799
Monoisotopic: 578.415568863
Chemical Formula
C30H54N6O5
InChI Key
BYUQATUKPXLFLZ-UIOOFZCWSA-N
InChI
InChI=1S/C30H54N6O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-27(37)33-22-28(38)35-26(20-24-21-32-23-34-24)29(39)36-25(30(40)41)17-15-16-19-31/h21,23,25-26H,2-20,22,31H2,1H3,(H,32,34)(H,33,37)(H,35,38)(H,36,39)(H,40,41)/t25-,26-/m0/s1
IUPAC Name
(2S)-6-amino-2-[(2S)-2-(2-hexadecanamidoacetamido)-3-(1H-imidazol-4-yl)propanamido]hexanoic acid
SMILES
CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
8407354

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
CreamTopical
PatchTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00146 mg/mLALOGPS
logP1.34ALOGPS
logP1.24ChemAxon
logS-5.6ALOGPS
pKa (Strongest Acidic)3.49ChemAxon
pKa (Strongest Basic)10.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area179.3 Å2ChemAxon
Rotatable Bond Count26ChemAxon
Refractivity158.79 m3·mol-1ChemAxon
Polarizability68.63 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on December 03, 2015 09:52 / Updated on September 02, 2019 19:22